<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>MAMA</italic> Powder and 
 <italic>MAMA</italic> Decoction are authorized indigenous polyherbal antimalarials which have been scientifically formulated by Prof Elujoba, the Head of the Village Chemist located within Obafemi Awolowo University, Ife, Nigeria. 
 <italic>MAMA</italic> Powder contains stem bark of 
 <italic>Alstonia boonei</italic> De Wild (Apocynaceae) and seed of 
 <italic>Picralima nitida</italic> Stapf (Apocynaceae) while 
 <italic>MAMA</italic> Decoction is made up of the leaves of 
 <italic>Mangifera indica</italic> L. (Anacardiaceae), 
 <italic>Alstonia boonei</italic> De Wild (Apocynaceae), 
 <italic>M. lucida</italic> and 
 <italic>Azadirachta indica</italic> A. Juss (Meliaceae) (
 <xref rid="B202" ref-type="bibr">Odediran et al., 2014</xref>). In an 
 <italic>in vivo</italic> experiment using rodents (
 <xref rid="B4" ref-type="bibr">Adepiti et al., 2014</xref>), 
 <italic>MAMA</italic> Decoction showed antimalarial activity at 240 mg/kg without any observable toxic effect when administered up to 2 g/kg body weight. Human observational study has further reinforced the 
 <italic>in vivo</italic> activity while the efficacy claims by treated patients on 
 <italic>MAMA</italic> herbal remedy has multiplied malarial patients’ demand for the herbal medicine. An elaborate preclinical study with superior scientific quality, documentation of chemical fingerprint as well as clinical trial and a possible repurposing for COVID-19 management is encouraged.
</p>
